Researchers
Janković, Slobodan
Results 21-40 of 679
| Issue Date | Title | Author(s) | Type | Мp-cat. |
|---|---|---|---|---|
| 2025 | Early-career pre-congress meetings: investing in talent, transforming the future of clinical pharmacology | Belancic, Andrej; Litonius, Kaisa; Kulla, Noora; Likic, Robert; Jankovic, Slobodan   ; Vitezic, Dinko; Backman, Janne T | Contribution to periodical | 22M22 |
| 2025 | Preventable serious drug-disease interactions of reserve antibiotics | Jankovic, Slobodan M ; Jankovic, Snezana V; Stojadinovic, Dobrivoje S | Reviews | 21M21 |
| 2025 | Analysis of Reporting Trends of Serious Adverse Events Associated With Anti-Obesity Drugs | Raicevic, Branislava B; Belancic, Andrej; Mirkovic, Nikola ; Jankovic, Slobodan M | Article | 22M22 |
| 2025 | Cost-utility analysis of nusinersen–risdiplam switch in patients with spinal muscular atrophy in Croatia: A discrete event simulation model | Belančić, Andrej; Stević, Ivana ; Gkrinia, Elvira Meni Maria; Vitezić, Dinko; Janković, Slobodan | Article | 21M21 |
| 2025 | Pharmacokinetics of therapies approved for spinal muscular atrophy: A narrative review of current evidence | Sel, Eda Kubra; Gkrinia, Elvira Meni Maria; Roncato, Rossana; Vitezic, Dinko; Jankovic, Slobodan ; Belancic, Andrej | Article | 22M22 |
| 2025 | No pharmacovigilance signal of intracranial hypertension associated with glycylcyclines: a FAERS-based disproportionality analysis | Jankovic, Slobodan M ; Vujovic, Bojana; Zamora, Coronado Allison Rebecca; Mendes, Duarte Giovanna; Pontes, de Oliveira Tenorio Beatriz; Rekik, Ahmed; Ennouri, Yassine | Article | 21M21 |
| 2025 | Professional drivers’ knowledge about the influence of medicines that may impair driving | Antonić, Roland; Pešić Ivanović, Милица; Jevtić, Danijela; Popović, Kosana; Bogdanović Vasić, Slobodanka; Janković, Slobodan ; Folić, Marko | Article | 51M51 |
| 2025 | Predicting intermediate-risk prostate cancer using machine learning | Stojadinovic, Miroslav; Stojadinovic, Milorad; Jankovic, Slobodan | Article | 22M22 |
| 2025 | Clinical advances in investigational epilepsy treatments | Jankovic, Slobodan M | Article | 21aM21a |
| 2025 | Cost Analysis of Hospital Treatment for Peritoneal Dialysis-Associated Peritonitis | Stojadinović, Milorad M.; Živković-Zarić, Radica S. ; Petrović, Dejan S. ; Kezić, Aleksandra V. ; Radović, Milan M.; Jovičić-Pavlović, Svetlana M.; Mrđa, Ivana; Hadži-Tanović, Lara; Knežević, Violeta ; Pilčević, Dejan D. ;
Jemcov, Tamara K.
; Karapandžić, Marija; Janković, Slobodan M. ; | Article | 22M22 |
| 2025 | Enhancing the Prediction of Clinically Significant Prostate Cancer Through Feature Engineering | Stojadinović, Miroslav; Jurišević, Nebojša ; Stojadinović, Milorad; Janković, Slobodan | Article | 22M22 |
| 2025 | Predictors of Ceftazidime PK/PD Index Target Values and Toxic Plasma Levels in Adult Hospitalised Patients | Jankovic, Slobodan M ; Petrovic, Nemanja Z; Milovanovic, Dragan ; Rosic, Nikola; Milojevic-Corbic, Mirjana L; Folic, Marko ; Dejana-Ruzic-Zecevic; Zivkovic-Zaric, Radica; Stefanovic, Srdjan ; Pavlovic, Mladen ;
Obrenovic, Svetlana; Kostic, Marina J
; | Article | 23M23 |
| 2025 | Physiologically Based Pharmacokinetic and Toxicokinetic Modeling: A Multidisciplinary Approach to Drug Development and Ecotoxicology | Todorović, Nemanja ; Ćoškov, Aleksandra ; Andrić, Nebojša ; Stanić, Bojana ; Milijašević, Boris ; Milošević, Nataša ; Janković, Slobodan ; Lalić-Popović, Mladena | Article | 52M52 |
| 2025 | Risk factors for severe adverse drug reactions in hospitalized patients | Petrovic, Nemanja Z; Pejcic, Ana V ; Milosavljevic, Milos N ; Jankovic, Slobodan M | Article | 21M21 |
| 2025 | Modifications to Prostate Cancer Diagnosis following COVID-19 and Following Models | Stojadinovic, Miroslav M ; Stojadinovic, Milorad M; Jankovic, Slobodan M | Article | 22M22 |
| 2025 | Safety and efficacy of fondaparinux use in hemodialysis patients with heparin-induced thrombocytopenia: a systematic review | Stojadinović, Milorad ; Janković, Slobodan ; Živković-Zarić, Radica ; Baralić, Marko ; Jovičić-Pavlović, Svetlana; Bontić, Ana; Petrović, Nemanja; Pejčić, Ana | Article | 22M22 |
| 2025 | Nonchemotherapy drug-induced cytopenias: A cost-of-illness study using the microcosting methodology based on real-world data | Stevic, Ivana ; Jankovic, Slobodan M ; Petrovic, Nemanja; Canak-Baltic, Natasa; Marinkovic, Valentina D ; Lakic, Dragana M | Article | 21M21 |
| 2025 | Safety Profile of Antipsychotics as Predictors of the Quality of Life in Patients with Schizophrenia-An Inpatient Welfare Institution-Based Cross-Sectional Study | Petrovic, Aleksandra D; Barjaktarevic, Ana M ; Kostic, Olivera Z ; Mijailovic, Sara S ; Jankovic, Slobodan M ; Andjelkovic, Marija V ; Stanojevic-Pirkovic, Marijana S; Parezanovic-Ilic, Katarina D; Janjic, Vladimir S ; Mojsilovic, Jana ;
Arsenijevic, Jana; Jovanovic, Danijela B
; Knezevic, Sanja; Folic, Nevena ; Stevic, Milovan; Ruzic-Zecevic, Dejana T; Petrovic, Nemanja Z; Kostic, Marina J ; | Article | 21aM21a |
| 2025 | Risk factors for urinary tract infection and asymptomatic bacteriuria after stroke | Jankovic, Vladimir S; Miletic-Drakulic, Svetlana D; Jankovic, Slobodan M ; Lazarevic, Snezana R; Radevic, Sandra M; Jovovic, Ivana P | Article | 22M22 |
| 2025 | Diverging Safety Signals: A Trend Analysis of Suspected Adverse Drug Reactions Reporting for Spinal Muscular Atrophy Therapies in the European Union | Belančić, Andrej; Mas, Petar; Stević, Ivana ; Vitezić, Dinko; Janković, Slobodan | Article | 21M21 |